An acute, but controlled increase in circulating IL-6 levels, as observed in our work, might transiently trigger IL-6 signaling in relevant immune subsets, such as Th2 cells, and initiate a protective tolerance response very early during AIT in VAP. Here, IL6 is linked to ventilator-associated pneumonia.